News
-
Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria - an Ultra-Rare Genetic Disorder that Causes Rapid Aging
-
iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 24-25, 2025
-
Rio Grande Resources Announces Positive Assay Results From its Sampling and Field Campaign at the Winston Gold-Silver Project, New Mexico USA
-
Brenmiller Energy Comments on Reverse Share Split Ahead of Expected Near-Term Milestones
-
MIRA Pharmaceuticals' Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology
-
Notice concerning the placement of 110,000 registered shares in Emmi AG
-
Information relative au placement de 110'000 actions nominatives d'Emmi SA
-
Cerinnov Group: Suspension de cours à compter du 17 juin 2025
-
PharmaSGP SE plans to redeem own shares – conditions for squeeze-out under conversion law are met
-
CEO Christian Grotholt remains major shareholder. Transfer of Mr. Grotholt’s 2G shares (29.6 %) to his own asset management company represents the only change.
-
Saint-Gobain enhances its digital construction chemicals platform with the acquisition of Maturix
-
Saint-Gobain renforce son offre digitale dans la chimie de la construction avec l’acquisition de Maturix
-
COGELEC : Compte rendu de l’Assemblée Générale Mixte du 4 juin 2025.
-
Frédéric Chevalier appointed CEO of Lagardère Travel Retail, alongside Dag Rasmussen, effective 1st July, 2025
-
Frédéric Chevalier est nommé Directeur Général de Lagardère Travel Retail aux côtés de Dag Rasmussen, à compter du 1er juillet 2025.